Vimarsana.com

Latest Breaking News On - Yigal nochomovitz - Page 3 : vimarsana.com

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript

Operator: Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode.

United-states
West-virginia
New-york
Americans
America
American
Roanna-ruiz
John-geelan
Jeffrey-wade
Jalan-main
Yigal-nochomovitz
Tom-garner

Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript

Ardelyx, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13. Ardelyx, Inc.

Mike-raab
Roanna-ruiz
Justin-renz
Ryan-deschner
Bunny-carter
Chris-raymond
Yigal-nochomovitz
Raymond-james
Piper-sandler
Louise-chen
Susan-rodriguez

Zai Lab Limited (NASDAQ:ZLAB) Q4 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

China
Prague
Praha
Hlavníesto
Czech-republic
United-states
Washington
Chinese
Rafael-amado
Yajing-chen
Michael-yee
Anupam-rama

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript

Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.66. Apellis Pharmaceuticals, Inc.

United-states
American
America
Raymond-james
Tim-sullivan
Tazeen-ahmad
Colleen-kusy
Salveen-richter
Cedric-francois
Jon-miller
Yigal-nochomovitz
Madam-townsend

Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results - Krystal Biotech (NASDAQ:KRYS)

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.

Debjit-chattopadhyay
Yigal-nochomovitz
Krishs-krishnan
Krystal-biotech-inc
Citigroup
Krystal-biotech

vimarsana © 2020. All Rights Reserved.